Curaleaf Holdings (TSX:CURA) Cyclically Adjusted Revenue per Share: C$9.16 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSX:CURA Curaleaf Holdings Inc TSX:CURA
76 GF Score
Price C$13.12
GF Value C$11.36
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Curaleaf Holdings Cyclically Adjusted Revenue per Share?

Curaleaf Holdings TSX:CURA -4.16% 76 Cyclically Adjusted Revenue per Share is C$9.16 as of Mar. 2026. GuruFocus rates TSX:CURA with a GF Score™ of 76/100 and a GF Value™ of C$11.36 (Modestly Overvalued). The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Curaleaf Holdings's adjusted revenue per share for the three months ended in Mar. 2026 was C$1.686. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is C$9.16 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Curaleaf Holdings's average Cyclically Adjusted Revenue Growth Rate was 0.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2026-07-17), Curaleaf Holdings's current stock price is C$13.12. Curaleaf Holdings's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was C$9.16. Curaleaf Holdings's Cyclically Adjusted PS Ratio of today is 1.43.

During the past 12 years, the highest Cyclically Adjusted PS Ratio of Curaleaf Holdings was 1.77. The lowest was 0.35. And the median was 1.06.


Curaleaf Holdings  (TSX:CURA) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Curaleaf Holdings's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=13.12/9.16
=1.43

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 12 years, the highest Cyclically Adjusted PS Ratio of Curaleaf Holdings was 1.77. The lowest was 0.35. And the median was 1.06.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Curaleaf Holdings Cyclically Adjusted Revenue per Share Related Terms


Curaleaf Holdings Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Curaleaf Holdings's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Curaleaf Holdings Cyclically Adjusted Revenue per Share Chart

Curaleaf Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 9.09 9.06

Curaleaf Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.14 9.15 9.14 9.06 9.16

TSX:CURA vs ZTS, UTHR: Cyclically Adjusted Revenue per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Curaleaf Holdings's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Curaleaf Holdings Cyclically Adjusted PS Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Curaleaf Holdings's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Curaleaf Holdings's Cyclically Adjusted PS Ratio falls into.


TSX:CURA
76GF Score
Curaleaf Holdings Inc TSX:CURA
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Curaleaf Holdings Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Curaleaf Holdings's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=1.686/330.2130*330.2130
=1.686

Current CPI (Mar. 2026) = 330.2130.

Curaleaf Holdings Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 0.000 241.018 0.000
201609 0.000 241.428 0.000
201612 0.000 241.432 0.000
201703 0.000 243.801 0.000
201706 0.000 244.955 0.000
201709 2.101 246.819 2.811
201712 20.726 246.524 27.762
201803 0.092 249.554 0.122
201806 0.151 251.989 0.198
201809 0.217 252.439 0.284
201812 0.295 251.233 0.388
201903 0.312 254.202 0.405
201906 0.419 256.143 0.540
201909 0.529 256.759 0.680
201912 0.636 256.974 0.817
202003 0.796 258.115 1.018
202006 0.896 257.797 1.148
202009 1.158 260.280 1.469
202012 1.575 260.474 1.997
202103 1.439 264.877 1.794
202106 1.626 271.696 1.976
202109 1.706 274.310 2.054
202112 1.675 278.802 1.984
202203 1.586 287.504 1.822
202206 1.769 296.311 1.971
202209 1.837 296.808 2.044
202212 1.938 296.797 2.156
202303 1.901 301.836 2.080
202306 1.859 305.109 2.012
202309 1.865 307.789 2.001
202312 1.896 306.746 2.041
202403 1.848 312.332 1.954
202406 1.900 314.175 1.997
202409 1.809 315.301 1.895
202412 1.838 315.605 1.923
202503 1.767 319.799 1.825
202506 1.703 322.561 1.743
202509 1.738 324.800 1.767
202512 1.732 324.054 1.765
202603 1.686 330.213 1.686

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of C$9.16 mean?
Curaleaf Holdings (TSX:CURA) has a Cyclically Adjusted Revenue per Share of C$9.16 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Curaleaf Holdings and its competitors.
Is Curaleaf Holdings' Cyclically Adjusted Revenue per Share too high?
Curaleaf Holdings' current Cyclically Adjusted Revenue per Share is C$9.16. Overall, Curaleaf Holdings has a GF Score™ of 76/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Curaleaf Holdings' Cyclically Adjusted Revenue per Share compare to ZTS and UTHR?
Curaleaf Holdings' Cyclically Adjusted Revenue per Share of C$9.16 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Revenue per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Curaleaf Holdings and its competitors. Curaleaf Holdings's current Cyclically Adjusted Revenue per Share is C$9.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Curaleaf Holdings stock overvalued right now?
Based on GuruFocus' analysis, Curaleaf Holdings (TSX:CURA) is currently considered Modestly Overvalued. The stock's GF Value™ is C$11.36, compared to a current price of C$13.12 — trading 15.5% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is C$9.16. Curaleaf Holdings' overall GF Score™ is 76/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Curaleaf Holdings (TSX:CURA), the current Cyclically Adjusted Revenue per Share is C$9.16 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Curaleaf Holdings (TSX:CURA) Overvalued in 2026?

Based on GuruFocus' analysis, Curaleaf Holdings stock appears to be overvalued. The current stock price of C$13.12 is trading 15.5% above its estimated GF Value™ of C$11.36. GuruFocus considers Curaleaf Holdings to be Modestly Overvalued.

Key valuation signals for TSX:CURA:

  • Cyclically Adjusted Revenue per Share: C$9.16
  • GF Value™: C$11.36 vs. price of C$13.12 (15.5% above fair value)
  • GF Score™: 76/100 with 5 warning signs

No single metric tells the full story. See the TSX:CURA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Curaleaf Holdings Business Description

Other Exchanges CURLD:USA2XW:Germany
Address 290 Harbor Drive, Stamford, CT, USA, 06902
Curaleaf is headquartered in Wakefield, Massachusetts, and cultivates and sells medicinal and recreational cannabis in the US. The company has operations in 17 states. Its brands include Curaleaf, Select, and Grassroots. The company has made acquisitions that give it exposure to the growing European market, a unique feature among US multistate operators.
76GF Score

Get the complete analysis for TSX:CURA

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$13.12
Price
C$11.36
GF Value